Healthtech Startups

GENinCode provides genomic testing for cardiovascular disease prevention and diagnosis using monogenic and polygenic risk assessment to identify patient risk and enable targeted preventive treatment. The company also offers testing for ovarian cancer surveillance, leveraging its proprietary software platform to combine genetic profiles with clinical risk factors.

1 investor

Genascence develops gene therapy treatments for musculoskeletal diseases, with a focus on osteoarthritis. It aims to apply gene therapy to highly prevalent conditions rather than only rare disorders.

1 investor

Genase Therapeutics is a biotech company developing cancer therapies that target metabolic vulnerabilities in oncogene-addicted cancers. Its team has prior experience advancing oncology drugs from preclinical stage to market.

1 investor

GenBody manufactures rapid diagnostic test kits, fluorescence immunoassay kits, and analysis equipment for human and veterinary use, including tests for infectious diseases, drug screening, and chronic conditions. The company also produces laboratory animals for research purposes.

1 investor

GenDx develops molecular diagnostic reagents, software, and services for transplant patient outcomes. Operating globally since 2005, the company serves the healthcare and diagnostics industry with specialized tools for transplant diagnostics.

1 investor

Gene BioSystems manufactures ready-to-use qPCR reagent kits for quantitative PCR analysis across major real-time PCR systems. The products are designed for research laboratories and diagnostic facilities requiring molecular biology testing reagents.

1 investor

GeneDx provides advanced genetic testing and clinical interpretation services to help clinicians diagnose rare and inherited genetic disorders, with AI-driven genomic intelligence that supports patient care decisions and accelerates research and drug discovery.

1 investor

GeneLancet develops proprietary LgRNA technology for precise gene editing, with applications in CRISPR polymerase-directed therapies targeting neurodegenerative diseases and cancers with unmet medical needs.

1 investor

Generable develops statistical and computational models for drug development and healthcare decision-making, leveraging Bayesian methods and probabilistic modeling. The company serves pharmaceutical and biotech organizations in developing safer and more efficient therapeutic interventions.

1 investor

General Biotechnologies manufactures peptide therapeutics by genetically programming edible microbes to synthesise molecules, aiming to produce them at lower cost. It focuses on reviving clinically proven but discontinued off-patent peptides as low-cost oral drugs, including an oral GLP-1, and partners with pharma companies to bring shelved assets back as oral formulations.

1 investor

General Fluidics builds Axess, a point-of-care diagnostic analyzer powered by its patented Embedded Fluidics Systems that runs clinical chemistry, hematology, and immunoassay panels from a single cartridge in under 20 minutes. It targets decentralized healthcare settings such as doctors' offices and clinics, enabling reference-lab-quality blood test results during a single patient visit.

1 investor

GeneralPractice.AI is a platform for primary care clinicians that generates personalized prevention and lifestyle medicine plans during routine consultations. It helps GPs deliver structured, evidence-based management plans for chronic disease prevention and health optimization without adding administrative burden.

1 investor

Generate Life Sciences was a reproductive, newborn stem cell, and genetic services company offering products and services to help families grow and protect their families. It has been acquired by CooperSurgical.

1 investor

Genesis Automation Healthcare provides a clinical lifecycle management platform that bridges the gap between ERP and EHR systems in healthcare organizations. The platform consolidates supply chain operations across hospital facilities to improve inventory management, patient safety, and financial performance.

1 investor

GenesisTissue is a 3D bioprinting company that designs and manufactures personalized regenerative tissue implants for humans. It operates in the regenerative medicine and medical implant space.

1 investor

Adapsyn Bioscience is a biotechnology company that uses proprietary algorithms and artificial intelligence to analyze genomic and metabolomic data from microbes in order to discover novel small molecule natural product drug candidates.

1 investor

GeneTech provides non-invasive prenatal testing (NIPT) using fetal cell-free DNA from maternal blood, along with clinical laboratory testing services, offered to certified medical institutions in Japan. It introduced NIPT in Japan in 2013 and runs a domestic analysis lab, serving pregnant patients and their families through partner hospitals.

1 investor

Genetica is an artificial intelligence-powered genetic testing company that analyzes hundreds of genes to provide scientific insights about physical traits, behavior, intelligence, and health risks for Asian populations. The company partners with leading genome sequencing organizations and aims to optimize personal development plans and protect individual and family health.

1 investor

Genetix Biotherapeutics develops gene addition therapies that use a patient's own cells to treat the underlying cause of rare diseases with a single dose, with a focus on hematology conditions such as sickle cell disease. The company has three FDA-approved one-time treatments for rare diseases.

1 investor

Genevation develops personalized mRNA cancer vaccines using an AI-driven neoantigen discovery platform and cell-free manufacturing, with pre-clinical programs targeting lung, colon, and skin cancers. The biotech company serves precision oncology and is based in the UK, expanding into the USA.

1 investor

GENEWIZ provides sequencing, synthesis, and molecular biology services for research, clinical, and therapeutic applications, serving academic institutions, biotech companies, and pharmaceutical organizations.

1 investor

GenieBiome (G-NiiB) develops microbiome-modifying technology and therapeutic candidates supported by clinical trials, using next-generation sequencing. The company focuses on treating human diseases through microbiome-based solutions.

1 investor

GeniPhys develops Collymer, a patented polymerizable (scaffold-forming) collagen technology used to design and fabricate collagen biomaterials for tissue restoration and regeneration. Its materials target regenerative medicine applications including soft tissue, cardiovascular, musculoskeletal, and orthopedic replacements, as well as delivery of pharmaceutical and cell-based therapies and device coatings.

1 investor

GeniusVets provides a marketing program for veterinary practices, including websites, search engine marketing, content, and a directory that helps pet owners find local vets. It serves veterinarians and veterinary clinics in the animal health industry.

1 investor